PCDASHB Stock Latest News
Private CompaniesDash Bio Targets Platform Expansion With New Assay Modalities and Series A Funding1d agoDASHB
Private CompaniesDash Bio Strengthens Automation Leadership to Support Platform Expansion4d agoDASHB
Private CompaniesDash Bio Strengthens Quality Infrastructure With New Specialist1w agoDASHB
Private CompaniesDash Bio Highlights Bioanalysis Capabilities at AAPS PharmSci 3601w agoDASHB
Private CompaniesDash Bio Strengthens Quality Leadership With Senior Hire1w agoDASHB
Private CompaniesDash Bio Showcases Automated Bioanalytical Lab Capabilities at Industry Seminar1w agoDASHBPrivate CompaniesDash Bio Gains Industry Recognition With AI-Driven Drug Development Infrastructure2w agoDASHB
Private CompaniesDash Bio Strengthens Project Delivery Leadership With Synthetic Biology Hire1M agoDASHB
Private CompaniesDash Bio – Weekly Recap1M agoDASHB
Private CompaniesDash Bio Strengthens Engineering Leadership With Principal Software Hire1M agoDASHB
Private CompaniesDash Bio – Weekly Recap1M agoDASHB
Private CompaniesDash Bio Adds Full-Stack Engineering Talent to Support Bioanalysis Platform1M agoDASHBPrivate CompaniesDash Bio Showcases Lab Informatics Expertise Through Industry Panel Participation1M agoDASHB
Private CompaniesDash Bio – Weekly Recap2M agoDASHB
Private CompaniesDash Bio Targets Drug Development Lab Automation With $30M Series A2M agoDASHB
Private CompaniesDash Bio Secures $30 Million Series A to Expand Automated Bioanalysis Platform2M agoDASHB
Private CompaniesDash Bio Expands Tech-First Bioanalysis Platform With New Hires and Automation Focus3M agoDASHB
Private CompaniesTech-First CRO Strategy Positions Dash Bio for Efficiency-Focused Bioanalysis Market3M agoDASHB
